»ó´Ü¿©¹é
±â»ç (Àüü 74°Ç)
[RTM] 2024³â ´ç´¢º´ °ü¸®Àü·« ¾÷µ¥ÀÌÆ® THE MOST 2024-02-07 14:50
[Sub Story] À§¿°È¯ÀÚ À§¾Ï¿¹¹æ¿¡ Á¦±ÕÄ¡·á ±Ç°í ÀÌ»óµ· ±âÀÚ 2024-01-12 13:20
[Interview] À§¿° ÀûÀÀÁõ ½ÃÀÛÀ¸·Î »óºÎÀ§Àå°üÁúȯ Àü¹Ý¿¡ Àú¿ë·® PPI ¿ªÇÒ Àü¸Á ÀÌ»óµ· ±âÀÚ 2024-01-11 16:13
[Sub Story] ¡°¹Ì¶õ¼º À§¿°¿¡ PPIs °í·ÁÇÒ ¼ö À־ ÀÌ»óµ· ±âÀÚ 2023-08-07 15:36
[Sub Story] À§¿°Ä¡·á¿¡ ÀÖ¾î Àú¿ë·® PPIsÀÇ ¿ªÇÒ°ú Ä¡·áÀü·«
New Option for Treatment Escorten meeting
THE MOST 2023-08-07 15:25
¶óÀÎ
[Interview] ¡°¿ì¼öÇÑ È¿°ú¿Í ¾ÈÀü¼ºÀ¸·Î ½Ã³ÊÁö ±â´ëÇÒ ¼ö ÀÖ´Â À§¿° Ä¡·áÁ¦¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:58
[Interview] ¡°Á¡¸·º¸È£Á¦, NSAID À¯¹ß¼º Á¡¸·¼Õ»ó Ä¡·á¿¡ È¿°úÀû¡± ÀÓ¼¼Çü ±âÀÚ 2023-02-06 17:46
[Interview] Àú¿ë·® PPIs·Î À§¿°Ä¡·á¿¡ »õ·Î¿î È°·Î ¸ð»ö ÀÌ»óµ· ±âÀÚ 2023-01-06 17:56
[Sub Story] ±¹³» À§¿° °ü¸®Àü·«, 8°³ Áú¹®¿¡ ´ã¾Ò´Ù ÀÓ¼¼Çü ±âÀÚ 2023-01-06 17:25
[Drug Review] ¹«ÄÚ½ºÅ¸, ¡®Æø³ÐÀº ±Ù°Å¡¯ÀÇ Á¡¸·º¸È£Á¦ ÀÓ¼¼Çü ±âÀÚ 2023-01-06 11:37
¶óÀÎ
[Deep in Guideline] ±â´É¼º ¼ÒÈ­ºÒ·®Áõ, »ê¾ïÁ¦Á¦¿¡¼­ Ç׿ì¿ïÁ¦±îÁö Àû¿ëÇÑ´Ù ÀÓ¼¼Çü ±âÀÚ 2023-01-06 10:46
[Sub Story] [NICE ¼ºÀÎ ¿ì¿ïÁõ Ä¡·á¡¤°ü¸® °¡À̵å¶óÀÎ]
¾à¹°¿ä¹ý°ú ºñ¾à¹°¿ä¹ýÀÇ ÀûÀýÇÑ »ç¿ë °­Á¶
ÀÓ¼¼Çü ±âÀÚ 2022-09-05 18:04
[Conference Report] Å×Á¦Æç·ç¸¿, ÁßÁõ õ½Ä Ä¡·áÈ¿°ú  ±Ù°Å È®º¸ ÀÓ¼¼Çü ±âÀÚ 2022-04-11 12:10
[Sub Story] ±â´É¼º ¼ÒÈ­ºÒ·®Áõ Ä¡·á
»ê¾ïÁ¦Á¦¿¡¼­ Àå¿îµ¿ÃËÁøÁ¦¡¤Ç︮ÄÚ¹ÚÅÍ¡¤Ç׿ì¿ïÁ¦±îÁö
ÀÌ»óµ· ±âÀÚ 2022-01-04 13:54
[Interview] ¡°ÀûÀýÇÑ À§¿° °ü¸® À§ÇÑ ´ë¾ÈÀ¸·Î ±â´ë¡± ÀÓ¼¼Çü ±âÀÚ 2022-01-04 11:54
¶óÀÎ
[Cover Story] ¾Ï ¿¹¹æ ¿°µÎ¿¡ µÐ ¼ÒÈ­±âÁúȯ °ü¸®Àü·« ÀÓ¼¼Çü ±âÀÚ 2021-01-22 13:45
[Sub Story] Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á Ç×»ýÁ¦¿¡¼­ P-CAB±îÁö ÀÓ¼¼Çü ±âÀÚ 2021-01-22 13:15
[Sub Story] ¼ÒÈ­ºÒ·®Áõ Áø´Ü ¶§ºÎÅÍ À§¾Ï ¿©ºÎÈ®ÀÎ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 12:00
[Sub Story] ¾Æ½ºÇǸ° + Ç×Ç÷¼ÒÆÇÁ¦ ¼ÒÈ­¼º±Ë¾ç À§Çè¡è ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:38
[Drug Review] ´Ã¾î³ª´Â NSAIDs ¼ÒÈ­¼º±Ë¾ç ¿¹¹æ ´ë¾È ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:45
Back to Top